EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab

Dionysios Kogias iD, Efstratios Gavriilidis, Christina Antoniadou, Aikaterini Skeva, Nikolaos Kafalis, Dimitrios Tsilingiris, George Kanellis, Maria Panopoulou, Ioannis Mitroulis, Konstantinos Ritis, Panagiotis Skendros, Georgios Kouklakis

Journal of Viral Hepatitis · 2025

DOI: 10.1111/jvh.70005 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Dionysios Kogias und 11 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece. Hauptthemen laut MEDLINE: Hepatitis E, Rituximab, Immunocompromised Host, Antibodies, Monoclonal, Murine-Derived. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis E virus (HEV) infection is a frequent cause of acute viral hepatitis. Immunocompromised patients, especially those under anti‐CD20 regimens, are prone to chronic or treatment‐resistant courses of hepatitis E. We report a case of chronic HEV infection in a 36‐year‐old man with a history of thrombotic thrombocytopenic purpura treated with rituximab 6 months ago, who presented with new‐onset painless jaundice and malaise. Laboratory tests and imaging revealed signs of inflammation and hepatic dysfunction. Due to initial suspicion of autoimmune hepatitis, corticosteroid therapy was started. However, liver biopsy and positive HEV RNA value redefined the diagnosis. Serology tests revealed initially acute infection, which later progressed to chronic hepatitis E infection. Treatment with ribavirin, along with supportive care, achieved significant clinical and laboratory improvement, resolving jaundice, restoring normal transaminase and suppressing HEV RNA values. Further review of the literature highlights the impact of immunosuppression caused by anti‐CD20 therapies on HEV infection, as well as the challenges in both treatment and achieving sustained virus clearance in such patients. Moreover, this report underlines the importance of HEV screening in patients with hepatitis who have undergone anti‐CD20 therapies, shedding light on a situation that is not well described in the literature and should not be overlooked, even in developed countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis ERituximabImmunocompromised HostAntibodies, Monoclonal, Murine-DerivedHumansMaleAdultAntiviral AgentsRNA, ViralRibavirinTreatment OutcomeLiverHepatitis E virusBiopsy

Stichwörter der Autor:innen

hepatitis Eimmunosuppressionribavirinrituximab

Substanzen

RituximabAntiviral AgentsRNA, ViralRibavirinAntibodies, Monoclonal, Murine-Derived

Autor:innen und Institutionen

  • First Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
  • Department of Microbiology, Democritus University of Thrace, Alexandroupolis, Greece.
  • Department of Hemopathology, Evangelismos General Hospital, Athens, Greece.

ORCID-Profile: Dionysios Kogias

Zitieren

APA

Kogias, D., Gavriilidis, E., Antoniadou, C., Skeva, A., Kafalis, N., Tsilingiris, D., Kanellis, G., Panopoulou, M., Mitroulis, I., Ritis, K., Skendros, P., & Kouklakis, G. (2025). Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70005

Vancouver

Kogias D, Gavriilidis E, Antoniadou C, Skeva A, Kafalis N, Tsilingiris D, et al. Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.70005

BibTeX
@article{Kogias2025,
  author = {Kogias, Dionysios and Gavriilidis, Efstratios and Antoniadou, Christina and Skeva, Aikaterini and Kafalis, Nikolaos and Tsilingiris, Dimitrios and Kanellis, George and Panopoulou, Maria and Mitroulis, Ioannis and Ritis, Konstantinos and Skendros, Panagiotis and Kouklakis, Georgios},
  title = {Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab},
  journal = {Journal of Viral Hepatitis},
  year = {2025},
  doi = {10.1111/jvh.70005}
}
Kostenlos starten →